Ultragenyx Pharmaceutical (RARE) Q2 2018 Earnings

7MayConfirmed
Q3 2017
Q4 2017
Q1 2018
Q2 2018
-2.04
-1.65
-1.26
-0.87

Details

Expected EPS
-0.87
Actual EPS
-2.03
Surprise EPS
-1.16
Surprise Percent
+133.33%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -2.03 per share for Q2 2018.

0 Comments

Share your thoughts